CFX96 optical reaction module for realtime PCR system with starter package 96-well optical module includes CFX maestro software, qbase, software license, cables, reagents, consumables for use with…
Ended Awarded
- Contract number
- 75N92B20F00016
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,495
Award facts
- Contract value 100% obligated
- $22,495.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rodeo, CA 94547, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics headquartered in Hercules, California, was awarded a $22,495 firm fixed-price Blanket Purchase Agreement (BPA) call on July 8, 2020, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract, with an ultimate completion date of December 31, 2020, covers a CFX96 optical reaction module for real-time polymerase chain reaction (PCR) systems, including a 96-well optical module, CFX Maestro software, QBase software license, cables, reagents, and consumables designed for use with the C1000 Touch thermal cycler chassis. The award carried no small business set-aside designation, reflecting Bio-Rad's established position as a large federal contractor. Performance of this contract took place in Hercules, California, where Bio-Rad's Life Science Group division maintains its operations.
This acquisition supports NIAMS' research capabilities in molecular biology and diagnostics, enabling sophisticated real-time PCR analysis essential for arthritis and musculoskeletal disease research. The contract was executed under a BPA framework, allowing NIAMS to procure specialized scientific instrumentation and consumables efficiently. Bio-Rad's extensive federal contracting history, including significant indefinite delivery vehicles with the National Institutes of Health and other government agencies, demonstrates the company's critical role in providing advanced laboratory technologies and support to federal research institutions across multiple scientific domains.
Description
CFX96 optical reaction module for realtime PCR system with starter package 96-well optical module includes CFX maestro software, qbase, software license, cables, reagents, consumables for use with C1000 touch thermal cycler chassis
Quick answers
Who was awarded contract 75N92B20F00016?
75N92B20F00016 was awarded to Bio-Rad Laboratories, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 8, 2020.
How much is contract 75N92B20F00016 worth?
The government has obligated $22,495 on 75N92B20F00016.
Is contract 75N92B20F00016 an order under another contract?
Yes. 75N92B20F00016 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract 75N92B20F00016 competed?
The extent of competition for 75N92B20F00016 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award